Difficulty: Medium
Average Score: 84%
Practice
Mycobat tuberculosis infection in a HI V infected patient is treated with
Correct answer
B
Rationale
The correct answer is B) Four first-line antitubercular drugs for 2 months followed by a longer continuation phase of 7 months with rifampin + isoniazid. This regimen is the standard treatment for Mycobacterium tuberculosis infection in a HIV-infected patient because it ensures effective treatment while considering the patient's immune status.
Option A is incorrect because HIV-infected patients require a longer duration of treatment due to their compromised immune system. Option C is incorrect as not all five first-line antitubercular drugs are necessary for the treatment of Mycobacterium tuberculosis infection, and using unnecessary medications can increase the risk of adverse effects.
Option D is incorrect because the combination of Clarithromycin, Ciprofloxacin, and Rifabutin is not the first-line treatment for tuberculosis and may not provide adequate coverage against the infection.
Educationally, it is crucial for healthcare professionals to understand the specific treatment regimens for tuberculosis in HIV-infected patients to ensure optimal patient care and outcomes. This knowledge helps in tailoring treatment plans based on individual patient characteristics, such as immune status, to provide the most effective and safe care.
Option A is incorrect because HIV-infected patients require a longer duration of treatment due to their compromised immune system. Option C is incorrect as not all five first-line antitubercular drugs are necessary for the treatment of Mycobacterium tuberculosis infection, and using unnecessary medications can increase the risk of adverse effects.
Option D is incorrect because the combination of Clarithromycin, Ciprofloxacin, and Rifabutin is not the first-line treatment for tuberculosis and may not provide adequate coverage against the infection.
Educationally, it is crucial for healthcare professionals to understand the specific treatment regimens for tuberculosis in HIV-infected patients to ensure optimal patient care and outcomes. This knowledge helps in tailoring treatment plans based on individual patient characteristics, such as immune status, to provide the most effective and safe care.